Analysis of CYP3A4 genetic polymorphisms in Han Chinese

Journal of Human Genetics

Volumn 56, Issue 6, 2011, Pages 415-422

  Zhou, Qing ^a   Yu, Xiaomin ^a,b   Shu, Chang ^a   Cai, Yimei ^a   Gong, Wei ^a   Wang, Xumin ^a   Wang, Duen Mei ^a   Hu, Songnian ^a  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CYP3A4; genetic polymorphisms; Han Chinese

Indexed keywords

CYTOCHROME P450 3A4;

3' UNTRANSLATED REGION; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; COMPUTER MODEL; ETHNIC DIFFERENCE; ETHNICITY; EXON; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; POSTTRANSCRIPTIONAL GENE SILENCING; PROMOTER REGION; PROTEIN CONFORMATION; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE; CYTOCHROME P-450 CYP3A; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MICRORNAS; MODELS, MOLECULAR; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; RNA INTERFERENCE; SELECTION, GENETIC; YOUNG ADULT;

EID: 79959684375     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2011.30     Document Type: Article

References (70)

1. Nicolas, J. M., Espie, P. & Molimard, M. Gender and interindividual variability in pharmacokinetics. Drug. Metab. Rev. 41, 408-421 (2009).
2. Wilkinson, G. R. Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: Some answers but still questions. Clin. Pharmacol. Ther. 76, 99-103 (2004). (Pubitemid 39013399)
3. Ozdemir, V., Kalow, W., Tang, B. K., Paterson, A. D., Walker, S. E., Endrenyi, L. et al. Evaluation of the genetic component of variability in CYP3A4 activity: A repeated drug administration method. Pharmacogenetics 10, 373-388 (2000). (Pubitemid 30433571)
4. Perera, M. A. The missing linkage: What pharmacogenetic associations are left to find in CYP3A? Expert. Opin. Drug. Metab. Toxicol. 6, 17-28 (2010).
5. Kedmi, M., Maayan, S., Cohen, S. B., Hauzi, M. & Rund, D. MDR1 and CYP3A4 polymorphisms are associated with HIV seropositivity in Israeli patients but do not influence the course of HIV disease. AIDS. Patient. Care. STDS. 21, 653-658 (2007). (Pubitemid 47525388)
6. Rebbeck, T. R., Troxel, A. B., Norman, S., Bunin, G., DeMichele, A., Schinnar, R. et al. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone- metabolism genotypes in postmenopausal breast cancer risk. Am. J. Epidemiol.166, 1392-1399 (2007). (Pubitemid 350209049)
7. Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J. & Malkowicz, S. B. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl. Cancer. Inst. 90, 1225-1229 (1998). (Pubitemid 28407089)
8. Tayeb, M. T., Clark, C., Sharp, L., Haites, N. E., Rooney, P. H., Murray, G. I. et al. CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol. Rep. 9, 653-655 (2002).
9. Yamada, Y., Matsuo, H., Watanabe, S., Kato, K., Yajima, K., Hibino, T. et al. Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus. Int. J. Mol. Med. 20, 703-707 (2007).
10. Kang, Y. S., Park, S. Y., Yim, C. H., Kwak, H. S., Gajendrarao, P., Krishnamoorthy, N. et al. The CYP3A4*18 genotype in the cytochrome P450 3A4 gene, a rapid metabolizer of sex steroids, is associated with low bone mineral density. Clin. Pharmacol. Ther. 85, 312-318 (2009).
11. Liu, C. H., Peck, K., Huang, J. D., Lin, M. S., Wang, C. H., Hsu, W. P. et al. Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip. Pharmacogenomics 6, 731-747 (2005). (Pubitemid 41479418)
12. Garsa, A. A., McLeod, H. L. & Marsh, S. CYP3A4 and CYP3A5 genotyping by Pyrosequencing. BMC. Med. Genet. 6, 19 (2005).
13. Schirmer, M., Toliat, M. R., Haberl, M., Suk, A., Kamdem, L. K., Klein, K. et al. Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations. Pharmacogenet. Genomics 16, 59-71 (2006). (Pubitemid 41803878)
14. Amirimani, B., Ning, B., Deitz, A. C., Weber, B. L., Kadlubar, F. F. & Rebbeck, T. R. Increased transcriptional activity of the CYP3A4*1B promoter variant. Environ. Mol. Mutagen. 42, 299-305 (2003). (Pubitemid 38054375)
15. Hu, Y. F., He, J., Chen, G. L., Wang, D., Liu, Z. Q., Zhang, C. et al. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population. Clin. Chim. Acta. 353, 187-192 (2005). (Pubitemid 40215445)
16. Lee, S. J., Lee, S. S., Jeong, H. E., Shon, J. H., Ryu, J. Y., Sunwoo, Y. E. et al. The CYP3A4*18 allele, the most frequent coding variant in Asian populations, does not significantly affect the midazolam disposition in heterozygous individuals. Drug. Metab. Dispos. 35, 2095-2101 (2007).
17. Yamamoto, T., Nagafuchi, N., Ozeki, T., Kubota, T., Ishikawa, H., Ogawa, S. et al. CYP3A4*18: It is not rare allele in Japanese population. Drug. Metab. Pharmacokinet.18, 267-268 (2003).
18. Ruzilawati, A. B., Suhaimi, A. W. & Gan, S. H. Genetic polymorphisms of CYP3A4: CYP3A4*18 allele is found in five healthy Malaysian subjects. Clin. Chim. Acta. 383, 158-162 (2007). (Pubitemid 47016453)
19. Westlind-Johnsson, A., Hermann, R., Huennemeyer, A., Hauns, B., Lahu, G., Nassr, N. et al. Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity. Clin. Pharmacol. Ther. 79, 339-349 (2006).
20. Zhao, T. M. & Lee, T. D. Gm and Km allotypes in 74 Chinese populations: A hypothesis of the origin of the Chinese nation. Hum. Genet. 83, 101-110 (1989). (Pubitemid 19234554)
21. Chu, J. Y., Huang, W., Kuang, S. Q., Wang, J. M., Xu, J. J., Chu, Z. T. et al. Genetic relationship of populations in China. Proc. Natl. Acad. Sci. USA 95, 11763-11768 (1998). (Pubitemid 28460488)
22. Wen, B., Li, H., Lu, D., Song, X., Zhang, F., He, Y. et al. Genetic evidence supports demic diffusion of Han culture. Nature 431, 302-305 (2004). (Pubitemid 39265663)
23. Gan, R. J., Pan, S. L., Mustavich, L. F., Qin, Z. D., Cai, X. Y., Qian, J. et al. Pinghua population as an exception of Han Chinese's coherent genetic structure. J. Hum. Genet. 53, 303-313 (2008).
24. Hsieh, K. P., Lin, Y. Y., Cheng, C. L., Lai, M. L., Lin, M. S., Siest, J. P. et al. Novel mutations of CYP3A4 in Chinese. Drug. Metab. Dispos. 29, 268-273 (2001).
25. Wen, S., Wang, H., Ding, Y., Liang, H. & Wang, S. Screening of 12 SNPs of CYP3A4 in a Chinese population using oligonucleotide microarray. Genet. Test. 8, 411-416 (2004). (Pubitemid 40083107)
26. Du, J., Xing, Q., Xu, L., Xu, M., Shu, A., Shi, Y. et al. Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population. Pharmacogenomics 7, 831-841 (2006). (Pubitemid 44446734)
27. International HapMap Consortium. The International HapMap Project. Nature 426, 789-796 (2003).
28. Zhou, Q., Yu, X. M., Lin, H. B., Wang, L., Yun, Q. Z., Hu, S. N. et al. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese. Pharmacogenomics J. 9, 380-394 (2009).
29. Lahiri, D. K. & Nurnberger, J. I. Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic. Acids. Res. 19, 5444 (1991).
30. Ewing, B., Hillier, L., Wendl, M. C. & Green, P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome. Res. 8, 175-185 (1998). (Pubitemid 28177229)
31. Ewing, B. & Green, P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome. Res. 8, 186-194 (1998). (Pubitemid 28177230)
32. Nickerson, D. A., Tobe, V. O. & Taylor, S. L. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic. Acids. Res. 25, 2745-2751 (1997). (Pubitemid 27299787)
33. Gordon, D., Abajian, C. & Green, P. Consed: A graphical tool for sequence finishing. Genome. Res. 8, 195-202 (1998). (Pubitemid 28177231)
34. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005). (Pubitemid 40202029)
35. Abecasis, G. R. & Cookson, W. O. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16, 182-183 (2000).
36. Stephens, M., Smith, N. J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989 (2001). (Pubitemid 32289743)
37. Stephens, M. & Scheet, P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76, 449-462 (2005). (Pubitemid 40250525)
38. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U. & Segal, E. The role of site accessibility in microRNA target recognition. Nat. Genet. 39, 1278-1284 (2007). (Pubitemid 47482690)
39. Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R. et al. PANTHER: A library of protein families and subfamilies indexed by function. Genome. Res. 13, 2129-2141 (2003). (Pubitemid 37161770)
40. Thomas, P. D. & Kejariwal, A. Coding single-nucleotide polymorphisms associated with complex vs Mendelian disease: Evolutionary evidence for differences in molecular effects. Proc. Natl. Acad. Sci USA 101, 15398-15403 (2004). (Pubitemid 39441553)
41. Ramensky, V., Bork, P. & Sunyaev, S. Human non-synonymous SNPs: Server and survey. Nucleic. Acids. Res. 30, 3894-3900 (2002). (Pubitemid 35012462)
42. Ekroos, M. & Sjogren, T. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc. Natl. Acad. Sci. USA 103, 13682-13687 (2006). (Pubitemid 44413967)
43. Binkowski, T. A., Naghibzadeh, S. & Liang, J. CASTp: Computed Atlas of Surface Topography of proteins. Nucleic. Acids. Res. 31, 3352-3355 (2003). (Pubitemid 37442157)
44. Librado, P. & Rozas, J. DnaSP v5: A software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25, 1451-1452 (2009).
45. Tajima, F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123, 585-595 (1989). (Pubitemid 19274682)
46. Fu, Y. X. & Li, W. H. Statistical tests of neutrality of mutations. Genetics 133, 693-709 (1993).
47. Fay, J. C. & Wu, C. I. Hitchhiking under positive Darwinian selection. Genetics 155, 1405-1413 (2000). (Pubitemid 30463447)
48. Voight, B. F., Kudaravalli, S., Wen, X. & Pritchard, J. K. A map of recent positive selection in the human genome. PLoS. Biol. 4, e72 (2006).
49. Yu, Z., Li, Z., Jolicoeur, N., Zhang, L., Fortin, Y., Wang, E. et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic. Acids. Res. 35, 4535-4541 (2007). (Pubitemid 47244604)
50. Chen, K. & Rajewsky, N. Natural selection on human microRNA binding sites inferred from SNP data. Nat. Genet. 38, 1452-1456 (2006). (Pubitemid 44837570)
51. Gao, Y., Zhang, L. R. & Fu, Q. CYP3A4*1G polymorphism is associated with lipidlowering efficacy of atorvastatin but not of simvastatin. Eur. J. Clin. Pharmacol. 64, 877-882 (2008).
52. Cavaco, I., Gil, J. P., Gil-Berglund, E. & Ribeiro, V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin. Chem. Lab. Med. 41, 1345-1350 (2003). (Pubitemid 37266126)
53. Chowbay, B., Zhou, S. & Lee, E. J. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: Experience in Singapore. Drug. Metab. Rev. 37, 327-378 (2005). (Pubitemid 40677508)
54. Fukushima-Uesaka, H., Saito, Y., Watanabe, H., Shiseki, K., Saeki, M., Nakamura, T. et al. Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population. Hum. Mutat. 23, 100 (2004).
55. Mizutani, T. PM frequencies of major CYPs in Asians and Caucasians. Drug. Metab. Rev. 35, 99-106 (2003). (Pubitemid 37048293)
56. Thompson, E. E., Kuttab-Boulos, H., Witonsky, D., Yang, L., Roe, B. A. & Di Rienzo, A. CYP3A variation and the evolution of salt-sensitivity variants. Am. J. Hum. Genet. 75, 1059-1069 (2004). (Pubitemid 39534403)
57. Du, J., Yu, L., Wang, L., Zhang, A., Shu, A., Xu, L. et al. Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations. Clin. Chim. Acta. 383, 172-174 (2007). (Pubitemid 47016454)
58. Yamaguchi, Y., Khan, K. K., He, Y. A., He, Y. Q. & Halpert, J. R. Topological changes in the CYP3A4 active site probed with phenyldiazene: Effect of interaction with NADPHcytochrome P450 reductase and cytochrome b5 and of site-directed mutagenesis. Drug. Metab. Dispos. 32, 155-161 (2004). (Pubitemid 38112548)
59. Ohkura, K., Kawaguchi, Y., Watanabe, Y., Masubuchi, Y., Shinohara, Y. & Hori, H. Flexible structure of cytochrome P450: Promiscuity of ligand binding in the CYP3A4 heme pocket. Anticancer. Res. 29, 935-942 (2009).
60. Brennecke, J., Stark, A., Russell, R. B. & Cohen, S. M. Principles of microRNA-target recognition. PLoS. Biol. 3, e85 (2005).
61. Budhu, A., Jia, H. L., Forgues, M., Liu, C. G., Goldstein, D., Lam, A. et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47, 897-907 (2008). (Pubitemid 351449681)
62. Navon, R., Wang, H., Steinfeld, I., Tsalenko, A., Ben-Dor, A. & Yakhini, Z. Novel rankbased statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS. One 4, e8003 (2009).
63. Simion, A., Laudadio, I., Prévot, P. P., Raynaud, P., Lemaigre, F. P., Jacquemin, P. et al. MiR-495 and miR-218 regulate the expression of the Onecut transcription factors HNF-6 and OC-2. Biochem. Biophys. Res. Commun. 391, 293-298.
64. Pogribny, I. P., Tryndyak, V. P., Ross, S. A. & Beland, F. A. Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats. Nutr. Rev. 66, S33-S35 (2008).
65. Wong, Q. W., Lung, R. W., Law, P. T., Lai, P. B., Chan, K. Y., To, K. F. et al. MicroRNA- 223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135, 257-269 (2008). (Pubitemid 351910680)
66. Mishra, P. J., Humeniuk, R., Longo-Sorbello, G. S., Banerjee, D. & Bertino, J. R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl. Acad. Sci. USA 104, 13513-13518 (2007). (Pubitemid 47293976)
67. Chen, K., Song, F., Calin, G. A., Wei, Q., Hao, X. & Zhang, W. Polymorphisms in microRNA targets: A gold mine for molecular epidemiology. Carcinogenesis 29, 1306-1311 (2008).
68. Tajima, F. DNA polymorphism in a subdivided population: The expected number of segregating sites in the two-subpopulation model. Genetics 123, 229-240 (1989). (Pubitemid 19233895)
69. Consortium, T. I. H. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
70. Przeworski, M. The signature of positive selection at randomly chosen loci. Genetics 160, 1179-1189 (2002). (Pubitemid 34263478)